Advertisement
Europe
Subscribe to Europe

The Lead

Single-use technology designed for cell cultures up to 2,000 L

May 21, 2015 4:39 pm | Sartorius Corporation | Product Releases | Comments

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has introduced Sartoclear Dynamics, a clarification system featuring new single-use technology for harvesting mammalian cell cultures with high cell densities.

Fibromyalgia Treatment Market Slowing

May 13, 2015 11:08 am | by GlobalData | News | Comments

The treatment market value for fibromyalgia across the seven major markets will reach $1.9...

Juno Acquires Stage Cell

May 12, 2015 11:15 am | by Juno Therapeutics | News | Comments

Juno Therapeutics, a biopharmaceutical company focused on cancer treatment, announced today that...

BASF Sells Part of Its Pharma Business

May 11, 2015 10:20 am | by Andy Szal, Digital Reporter | News | Comments

BASF recently announced plans to sell several prominent pharmaceutical ingredients to Siegfried...

View Sample

FREE Email Newsletter

Prostate Cancer Treatment Market To Grow To $8.2 Billion

April 30, 2015 11:46 am | News | Comments

The global treatment market value for prostate cancer will expand more than threefold by 2023.

Epigenomics Receives $3.1 Million Grant

April 29, 2015 11:15 am | by Epigenomics AG | News | Comments

Epigenomics AG today announced that the Company will receive an EU grant under the industrial leadership Horizon 2020 research and innovation program. 

Mylan Raises Offer To Acquire Perrigo

April 29, 2015 11:08 am | by Mylan | News | Comments

Mylan N.V. today announced that it has increased its offer to acquire the issued and to be issued shares of Perrigo.

Advertisement

Sartorius Stedim Biotech Acquires BioOutsource

April 17, 2015 12:10 pm | by Sartorius Stedim Biotech Group | News | Comments

Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.

Innate Pharma and Sanofi Collaboration

April 16, 2015 11:28 am | by Innate Pharma SA | News | Comments

Innate Pharma SA has entered into a collaboration with Sanofi to apply site-specific conjugation technology to the development of new Antibody Drug Conjugate

French Lawmakers OK Healthcare Bill Targeting Anorexia

April 15, 2015 10:53 am | by Sylvie Corbet, Associated Press | News | Comments

Too-thin models, too much drinking, sexy cigarette packs: France's parliament is cracking down on all of these in a sweeping bill designed to improve public health and trim public health costs.

Report: Policy Stunting Growth of German Pharma Industry

April 15, 2015 10:34 am | by Andy Szal, Digital Reporter | News | Comments

A 2011 law overhauling the German pharmaceutical industry will be the biggest impediment to growth in the sector over the next several years, according to a new report.

FDA Questions Evidence for Lower-Risk Tobacco Product

April 8, 2015 10:48 am | by Matthew Perrone, AP Health Writer | News | Comments

U.S. health regulators have questions about tobacco maker Swedish Match's bid to become the first to market a smokeless tobacco product as less harmful than cigarettes.

Advertisement

UK Prime Minister Apologizes for Tainted Blood Scandal

March 25, 2015 3:20 pm | News | Comments

British Prime Minister David Cameron on Wednesday apologized to thousands of patients who were infected from contaminated blood during the 1970s and 1980s.

German Court Orders Vaccination Cynic to Pay for Virus Proof

March 16, 2015 8:18 am | News | Comments

A German court has ruled that a prominent anti-vaccination advocate must pay a doctor 100,000 euros ($105,720) in prize money he had promised to anyone who could prove measles is a virus.

Johnson Matthey Commissions New High Containment Manufacturing Capacity in Edinburgh, UK

March 13, 2015 2:06 pm | News | Comments

Johnson Matthey, a provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion and commissioning of new high containment facilities for potent product manufacture at its Edinburgh, UK site (Macfarlan Smith).

Pernix to Acquire Zohydro® ER Franchise from Zogenix

March 11, 2015 8:14 am | News | Comments

Pernix Ireland Limited has signed a definitive agreement to acquire the Zohydro ER franchise from Zogenix, Inc. The acquisition includes three extended release hydrocodone products, including an abuse-deterrent pipeline and all related intellectual property.

Pfizer Receives European Approval for New Indication for Prevenar 13

March 3, 2015 8:47 am | News | Comments

Pfizer has announced that the European Commission approved an expanded indication for the use of Prevenar 13 for the prevention of pneumonia caused by the 13 pneumococcal serotypes in the vaccine in adults aged 18 years and older.

Advertisement

GSK Completes Transaction with Novartis

March 2, 2015 3:48 pm | News | Comments

Britain's GlaxoSmithKline PLC and Switzerland's Novartis AG have completed a three-part deal that will offer the British company's shareholders a 4 billion pound ($6.17 billion) windfall.

Life Sentence for German Nurse Who Killed Patients

February 26, 2015 3:21 pm | News | Comments

A German court sentenced a male nurse to life in prison on for killing patients with overdoses of heart medication that he confessed to administering because he enjoyed trying to revive them.

Catalent Expands European Clinical Packaging Capabilities

February 26, 2015 3:01 pm | News | Comments

Catalent Pharma Solutions has announced several expanded capabilities within its European Clinical Supply Services network. The expansions have been implemented in response to increased customer demand for specialty clinical packaging, where the proportion of highly-potent or temperature-sensitive investigational medical products continues to increase.

Biota Pharmaceuticals to Acquire Anaconda Pharma

February 26, 2015 8:07 am | News | Comments

Biota Pharmaceuticals has entered into a definitive agreement to acquire Anaconda Pharma, a privately-held biotechnology company based in Paris, France. Anaconda Pharma's lead candidate is AP611074, a patented, direct-acting antiviral in development.

UN Health Agency Urges Europe to Step Up Measles Vaccination

February 25, 2015 8:28 am | News | Comments

The World Health Organization is urging Europe to step up measles vaccination efforts as countries report thousands of cases of the disease.

Jacobs to Design Ireland Biologic Facility for BMS

February 24, 2015 8:03 am | News | Comments

Jacobs Engineering Group has received a contract from Bristol-Myers Squibb Company to provide architectural and engineering services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland.

Alkermes Appoints Senior Vice President of Research, Pharmaceutical and Nonclinical Development

February 23, 2015 8:24 am | News | Comments

Alkermes has appointed Mark Namchuk, Ph.D., as Senior Vice President of Research, Pharmaceutical and Nonclinical Development. Dr. Namchuk will be responsible for advancing the company’s early-stage product pipeline.

Hospira Launches First Biosimilar in Major European Markets

February 17, 2015 8:22 am | News | Comments

Hospira today announced the launch of the first biosimilar monoclonal antibody (mAb), Inflectra (infliximab), in major European markets. Inflectra is licensed for the treatment of inflammatory conditions including rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis, adult and paediatric Crohn's disease, adult and paediatric ulcerative colitis and plaque psoriasis.

Berlin Measles Traced to Refugees, But Two Cases Linked to US

February 13, 2015 8:00 am | News | Comments

Authorities in Berlin say a spike in measles infections has been traced to unvaccinated refugees but at least two measles cases appear to have come from the United States.

Bayer Announces Reorganization as ‘Pure Life-Sciences Company’

February 12, 2015 10:39 am | by Andrew Szal, Editor, Pharmaceutical Processing | News | Comments

The company announced the overhaul of its HealthCare, CropScience and other operations in a letter sent to employees Wednesday, though it indicated specific decisions on what the company will look like next January haven't yet been made.

GSK Acquires GlycoVaxyn for $212M

February 11, 2015 8:36 am | News | Comments

Edmond de Rothschild Investment Partners announced today that its BioDiscovery 3 portfolio company, GlycoVaxyn AG, a privately held specialist vaccine biopharmaceutical company, has been acquired by GlaxoSmithKline in an all-cash transaction valuing the company at approximately $212M.

Christie Declines to Take Questions After Vaccination Flap

February 3, 2015 1:15 pm | by JILL COLVIN, Associated Press | News | Comments

The Republican governor and likely presidential contender had originally been scheduled to address the press three times during the final day of his three-day trip to the United Kingdom. Instead, the availabilities vanished from his schedule, which included lunch with the chancellor of the exchequer and a visit to the famous Globe Theatre.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading